SCHEMBL29430215

SCHEMBL29430215

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ IL23R Q5VWK5 1/20 0.69
▸ NPY2R P49146 6/20 0.69
▸ NPY4R P50391 6/20 0.69
▸ NPY5R Q15761 6/20 0.69
▸ NPY1R P25929 4/20 0.69
▸ GLP1R P43220 11/20 0.62
▸ CCKBR P32239 2/20 0.62
▸ CXCR4 P61073 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29812652 0.91 NPY2R (0.72) NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29812657 0.91 NPY2R (0.72) NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29706357 0.90 NPY2R (0.71) NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29368944 0.90 NPY1R (0.70) NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29706164 0.90 NPY1R (0.69) IL23RNPY2RNPY4RNPY5RNPY1R
SCHEMBL29706113 0.89 NPY2R (0.70) NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL29812904 0.89 NPY1R (0.69) NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30607498 0.89 NPY2R (0.70) IL23RNPY2RNPY4RNPY5RNPY1R
SCHEMBL30615288 0.88 CXCR4 (0.68) IL23RNPY2RNPY4RNPY5RNPY1R
SCHEMBL30607284 0.87 NPY2R (0.64) IL23RNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220073636-A1 ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L DOMANTIS LIMITED (GB) 2022-03-10 — — US disclosed
Send feedback